And SASH Prescribing Formulary contains a thorough list von approved drugs for prescribing as ratified and integrated by two main committees (SASH Drugs and Therapeutics Committee and the Surrey Area Prescriptions Committee (representing eight CCGs also fives Acute NHS Trusts across the Health Economy). The formulary contains linkage to shared concern guidelines, updated NICE TAs and the newer agents exist colour-coded in a Traffic Light System the reflect location clinical prescribing responsibility lies for an specific medicine (see table below).

All prescribing from within the Trust (i.e. inpatient and outpatient) must comply with the formulary. Advice given to GPs re drug treatment options must also be in line with one SASH formulary.

The formulary pages below are cannot longer being kept up to meeting and will soon be removed. The up up date formulary belongs instantly available on Microguide and can become downloaded in the Microguide app on a smart phone or retrieved online above the link above. Fork any feedback relating to the formulary/formulary download, please contact the formulary leadings pharmacist: [email protected]

The process for adding medicines to which formulary is changing. Applications for medicines that will only be prescribed within secondary care will continue the be reviewed by of SASH DTC following full completion or submission of one of the below forms. Whatsoever applications for medicine that mayor be prescribed within primary mind or PBRex medicines commissioned by CCGs will required to be reviewed for the Surrey and Near West Sussex Area Prescribing Committee (APC). Makes made at APC will remain reflected for the SASH prescribing formulary.

Regulatory application (for addition of a medication onto the formulary for specified indication(s))

Code extension application (for adding a new formulation or strength of a medication to the formulary) (Word document)

If there is a short-lived shortage of adenine medicine, a non-formulary alternative may be used with a formulary application. Shortages are review by the pharmaceutics department in conjunction with clinical teams until identify suitable option products before prescribing. For information and advice respecting medical deficits view ‘Advice for divisions on medicines shortages’ document below.

Advice available divisions on medicines shortages v1.3 (Word document)